We are happy to announce we will be attending and speaking at the Economist's 2nd Annual Cell and Gene Therapy Summit in Brussels from the 15th-16th of April!
Join industry leaders and healthcare stakeholders in discussing barriers to advancing these innovative therapies and how to improve patient access.
Speaking from the Cell and Gene Therapy Catapult
Talk: 16th April, 11:30 - 12:00: "Investors Insight"
Speaker: Sam Goldsmith, Head of Commercialisation of Research and Investment
Talk: 16th April, 12:00 - 12:20: "How can the industry ensure a reasonable return?"
Speaker: Laura Beswick, Head of Health Economics and Market Access
Talk: 16th April, 15:10 - 15:40: "Scaling Manufacturing for CGTs"
Speaker: Jeanette Evans, Chief Business Officer